References
1. Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H. Acetaminophen‐induced hepatic injury: Protective role of glutathione in man and rationale for therapy. Clin Pharm Ther . 1974;4:676-684.
2. Prescott LF, Park J, Ballantyne A, et al. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. . Lancet . 1977;2(8035):432-434.
3. Prescott LF, Sutherland GR, Park J, Smith IJ, Proudfoot AT. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet . 1976;2(7977):109-113.
4. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J . 1979;2(6198):1097-1100.
5. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med . 1988;319(24):1557-1562. doi:10.1056/NEJM198812153192401
6. Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and duration: Past, present and future. Clin Toxicol . 2012;50(2):91-98. doi:10.3109/15563650.2012.659252
7. Bateman DN, Dear JW. Acetylcysteine in paracetamol poisoning: A perspective of 45 years of use. Toxicol Res (Camb) . 2019;8(4):489-498. doi:10.1039/c9tx00002j
8. Bateman DN, Dear JW, Thanacoody HKR, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: A randomised controlled trial. Lancet . 2014;383(9918):697-704. doi:10.1016/S0140-6736(13)62062-0
9. Chiew A, Gluud C, Brok J, Buckley N. Interventions for paracetamol ( acetaminophen ) overdose. Cochrane Database Syst Rev . 2018;(2):1-90. doi:10.1002/14651858.CD003328.pub3.www.cochranelibrary.com
10. Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning.Bmj . 2011;342(7804):968-972. doi:10.1136/bmj.d2218
11. Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther . 1974;16(4):676-684.
12. Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet . 1982;7(2):93-107.
13. Cairney DG, Beckwith HKS, Al-Hourani K, Eddleston M, Bateman DN, Dear JW. Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine. Clin Toxicol . 2016;54:405-410.
14. Marks DJ, Dargan PI, Archer JR, et al. Outcomes from massive paracetamol overdose: a retrospective observational study. Br J Clin Pharmacol . 2017;(83):1263-1272.
15. Chiew AL, Isbister GK, Duffull SB, Buckley NA. Evidence for the changing regimens of acetylcysteine. Br J Clin Pharmacol . 2016;81(3):471-481. doi:10.1111/bcp.12789
16. Bateman DN, Dear JW. Should we treat very large paracetamol overdose differently? Br J Clin Pharmacol . 2017;83(6):1163-1165. doi:10.1111/bcp.13279
17. Hendrickson RG. What is the most appropriate dose of N -acetylcysteine after massive acetaminophen overdose? Clin Toxicol . 2019;57(0):686-691. doi:10.1080/15563650.2019.1579914
18. Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol . 2018;17(April):274-283. doi:10.1016/j.redox.2018.04.019
19. Ramachandran A, Jaeschke H. Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology.J Clin Transl Res . 2017;3:157-169. doi:10.18053/jctres.03.2017s1.002
20. Jaeschke H, Ramachandran A. Acetaminophen Toxicity: Novel Insights Into Mechanisms and Future Perspectives. Gene Expr . 2018;18:19-30. doi:10.3727/105221617X15084371374138
21. Ezeriņa D, Takano Y, Hanaoka K, Urano Y, Dick TP. N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H 2 S and Sulfane Sulfur Production. Cell Chem Biol . 2018;25(4):447-459.e4. doi:10.1016/j.chembiol.2018.01.011
22. Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther . 2014;141(2):150-159. doi:10.1016/j.pharmthera.2013.09.006
23. Karuppagounder SS, Alin L, Chen Y, et al. N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice. Ann Neurol . 2018;84(6):854-872. doi:10.1002/ana.25356
24. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Bmj . 1991;303(6809):1026-1029.
25. Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet . 1990;335(8705):1572-1573.
26. Ghannoum M, Kazim S, Grunbaum AM, Villeneuve E, Gosselin S. Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics. Clin Toxicol (Phila) . 2016;54(6):519-522. doi:10.1080/15563650.2016.1175006
27. Gosselin S, Juurlink DN, Kielstein JT, et al. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol . 2014;52(8):856-867. doi:10.3109/15563650.2014.946994
28. Woolum JA, Hays WB, Patel KH. Use of fomepizole, n-acetylcysteine, and hemodialysis for massive acetaminophen overdose. Am J Emerg Med . 2020;38(3):692.e5-692.e7. doi:10.1016/j.ajem.2019.09.026
29. Morrison EE, Oatey K, Gallagher B, et al. Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).EBioMedicine . 2019;46:423-430. doi:10.1016/j.ebiom.2019.07.013
30. Mullins ME, Yeager LH, Freeman WE. Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review.Clin Toxicol . 2020;58(12):1284-1296. doi:10.1080/15563650.2020.1798979
31. Caparrotta TM, Antoine DJ, Dear JW. Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature. Eur J Clin Pharmacol . 2018;74(2):147-160. doi:10.1007/s00228-017-2356-6
32. Vliegenthart AD, Kimmitt RA, Seymour JH, et al. Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury. Clin Pharmacol Ther . 2016;10. doi:10.1002/cpt.541
33. Dear JW. New Biomarkers for Drug-Induced Liver Injury.Hepatology . 2018;67(6):2479-2480. doi:10.1002/hep.29825
34. Nuzzo A, Salem S, Malissin I, et al. in acetaminophen poisoning : A prospective cohort study. U E G J . 2021;9:571-580. doi:10.1002/ueg2.12093
35. Pettie JM, Caparrotta TM, Hunter RW, et al. Safety and Efficacy of the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol Overdose. EClinicalMedicine . 2019;11:11-17. doi:10.1016/j.eclinm.2019.04.005